
Meanwhile, the company has also launched a potent combination of Sitagliptin and Metformin and branded it as Jankey M.
The company’s new brand identity brings together two hearts in purple and teal colours symbolising its commitment to science and…
Chartists believe that the short term trend of Nifty continues to be range-bound with support near 17400-17380.
Ami Organics is scheduled to make its stock market debut on Tuesday, 14 September, after receiving over 64 times subscription…
Nifty futures were trading 145 points or 0.95 per cent higher at 15,335 on Singaporean Exchange, suggesting a strong opening…
Wednesday is an important day for the market and a level based trading approach should be followed. For the Bank-Nifty,…
Pharmaceutical sector will reflect the full impact of COVID-19 restrictions on the back of pre-buying in chronic therapies in March…
We initiate coverage on Cadila Healthcare (CDH) with BUY and a Mar17 TP of `370.
Strengthens its presence in the gastroenterology segment Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has entered into a definitive…
Zydus Healthcare, a subsidiary of Cadila Healthcare, has acquired gastrointestinal brand ‘Actibile’ from drug firm Albert David for an undisclosed…
Total income of the company rose to Rs 2,428 crore for the third quarter
Government today approved five foreign investment proposals involving an inflow of Rs 6,050 crore including a Rs 5,000-crore plan of…
Torn notebook with record of ‘deficiencies’, plastic bags filled with shreds of paperwork, failure to adequately investigate and address consumer…
The letters were received for its two facilities in Gujarat Cadila Healthcare has received a warning letter from the US…
Gas importer Petronet LNG will buy liquefied natural gas (LNG) from Qatar’s Rasgas at virtually half the original cost, the…
Cadila Healthcare Ltd shares surged on Friday after the company posted 40.56 per cent jump in consolidated net profit to…
Pharma firm Cadila Healthcare Ltd posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second…
Cadila Healthcare’s (CDH) Q4 results were above our expectations. Revenue recorded a 16% growth…
In the pipeline are three novel biologics, 10 vaccines, and two new chemical entities set to complete phase 1 clinical…
Cadila’s new chemical entity (NCE) pipeline includes two new drugs being developed to treat diabetes and anaemia.
Zydus BSV has now become 100 per cent subsidiary of Cadila Healthcare
Loading…
Something went wrong. Please refresh the page and/or try again.